Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Parekh, Falgunee K
and
Richie, Thomas L
2007.
Characterization of Immune Reactivity Profiles Using Microarray Technology May Expedite Identification of Candidate Antigens for Next Generation Malaria Vaccines.
Clinical Chemistry,
Vol. 53,
Issue. 7,
p.
1183.
Druilhe, Pierre
and
Barnwell, John W
2007.
Pre-erythrocytic stage malaria vaccines: time for a change in path.
Current Opinion in Microbiology,
Vol. 10,
Issue. 4,
p.
371.
Willadsen, Peter
2008.
Antigen cocktails: valid hypothesis or unsubstantiated hope?.
Trends in Parasitology,
Vol. 24,
Issue. 4,
p.
164.
Kats, Lev M.
Wang, Lina
Murhandarwati, E. Elsa Herdiana
Mitri, Khosse
Black, Casilda G.
and
Coppel, Ross L.
2008.
Active immunisation with RAMA does not provide protective immunity against Plasmodium yoelii challenge despite its association with protective responses in endemic populations.
Vaccine,
Vol. 26,
Issue. 26,
p.
3261.
Greenwood, Brian M.
2008.
Control to elimination: implications for malaria research.
Trends in Parasitology,
Vol. 24,
Issue. 10,
p.
449.
Greenwood, Brian M.
Fidock, David A.
Kyle, Dennis E.
Kappe, Stefan H.I.
Alonso, Pedro L.
Collins, Frank H.
and
Duffy, Patrick E.
2008.
Malaria: progress, perils, and prospects for eradication.
Journal of Clinical Investigation,
Vol. 118,
Issue. 4,
p.
1266.
Purcell, Lisa A.
Wong, Kurt A.
Yanow, Stephanie K.
Lee, Moses
Spithill, Terry W.
and
Rodriguez, Ana
2008.
Chemically attenuated Plasmodium sporozoites induce specific immune responses, sterile immunity and cross-protection against heterologous challenge.
Vaccine,
Vol. 26,
Issue. 38,
p.
4880.
Purcell, Lisa A.
Yanow, Stephanie K.
Lee, Moses
Spithill, Terry W.
and
Rodriguez, Ana
2008.
Chemical Attenuation of
Plasmodium berghei
Sporozoites Induces Sterile Immunity in Mice
.
Infection and Immunity,
Vol. 76,
Issue. 3,
p.
1193.
BALLOU, W. R.
2009.
The development of the RTS,S malaria vaccine candidate: challenges and lessons.
Parasite Immunology,
Vol. 31,
Issue. 9,
p.
492.
Dharia, Neekesh V
Sidhu, Amar Bir Singh
Cassera, María Belén
Westenberger, Scott J
Bopp, Selina ER
Eastman, Rich T
Plouffe, David
Batalov, Serge
Park, Daniel J
Volkman, Sarah K
Wirth, Dyann F
Zhou, Yingyao
Fidock, David A
and
Winzeler, Elizabeth A
2009.
Use of high-density tiling microarrays to identify mutations globally and elucidate mechanisms of drug resistance in Plasmodium falciparum
.
Genome Biology,
Vol. 10,
Issue. 2,
McKee, Amy S
MacLeod, Megan KL
Kappler, John W
and
Marrack, Philippa
2010.
Immune mechanisms of protection: can adjuvants rise to the challenge?.
BMC Biology,
Vol. 8,
Issue. 1,
Good, Michael F.
and
Doolan, Denise L.
2010.
Malaria Vaccine Design: Immunological Considerations.
Immunity,
Vol. 33,
Issue. 4,
p.
555.
Dunachie, Susanna J.
Berthoud, Tamara
Keating, Sheila M.
Hill, Adrian V. S.
Fletcher, Helen A.
and
Gregson, Aric
2010.
MIG and the Regulatory Cytokines IL-10 and TGF-β1 Correlate with Malaria Vaccine Immunogenicity and Efficacy.
PLoS ONE,
Vol. 5,
Issue. 9,
p.
e12557.
Chilengi, Roma
and
Gitaka, Jesse
2010.
Is vaccine the magic bullet for malaria elimination? A reality check.
Malaria Journal,
Vol. 9,
Issue. S3,
White, Michael T.
Griffin, Jamie T.
Riley, Eleanor M.
Drakeley, Chris J.
Moorman, Ann M.
Sumba, Peter Odada
Kazura, James W.
Ghani, Azra C.
and
John, Chandy C.
2011.
Efficacy model for antibody-mediated pre-erythrocytic malaria vaccines.
Proceedings of the Royal Society B: Biological Sciences,
Vol. 278,
Issue. 1710,
p.
1298.
2014.
The Elusive Malaria Vaccine.
p.
327.
Dunachie, Susanna
Hill, Adrian V.S.
and
Fletcher, Helen A.
2015.
Profiling the host response to malaria vaccination and malaria challenge.
Vaccine,
Vol. 33,
Issue. 40,
p.
5316.
Njogu, Peter Mbugua
and
Chibale, Kelly
2015.
Attrition in the Pharmaceutical Industry.
p.
287.